News
Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...
Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.
Casper claimed that during the quarter, Thermo Fisher advanced its growth strategy, launching a range of high-impact ...
The top financial leader at Thermo Fisher Scientific Inc. plans to retire from the company in 2026 after more than a decade ...
Q2 2025 Earnings Call Transcript July 23, 2025 Thermo Fisher Scientific Inc. beats earnings expectations. Reported EPS is ...
In the bustling realm of life sciences, Thermo Fisher Scientific shows formidable resilience and innovation. The company's Q2 2025 earnings reveal a revenue of $10.85 billion, marking a 3% ...
StockStory.org on MSN21h
TMO Q2 Deep Dive: Pharma Strength, Tariff Adaptation, and Strategic Investments Shape OutlookLife sciences company Thermo Fisher (NYSE:TMO) reported Q2 CY2025 results , with sales up 3% year on year to $10.86 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results